- King’s College London
Alliance Management Team
Create a simple, national structure to support entry in the UK for industry-led research and trials.
The AMT uses expertise in data, digital and pharma and strong linkage to trials methodology, lived experience and expertise to support industry-led research and trials in the UK across the MH spectrum Supports industry-led research
The AMT is a wrap-around service for industry — linking companies with methodology expertise in trial design and delivery, the lived experience partnership, bespoke IP and royalty strategies, funding applications and advisory board development. It provides a seamless structure that is simple to navigate for companies of every size, complementing the NIHR Innovation Service (opens in a new tab) and the MRC Mental Health Platform (opens in a new tab).
Primary focus
- Understanding barriers to working with UK
- Developing alliances and partnerships with industry
- Creating tools to support an improved landscape for planning studies and trials with various partners
Key questions & challenges
- How do we make planning studies in the UK better for industry?
- Can we empower industry to discover UK cohorts/sites?
- Can we create innovative partnerships to improve MH diagnosis and treatment?
How this differs from other infrastructure
- We focus on discovery and planning more than delivery where we expect to link-up with sites, cohorts, MHM, TRCs, RDNs
- We focus on tools developed with industry in mind to support entry in the UK
- We work across the entirety of MH, including psychiatric symptoms in neurodegenerative disorders
Who leads this workstream
Alliance Management Team Co-Lead · DIGIT Lead
King’s College London
Chief Industry, Data Science and Digital Health Officer · Alliance Management Team Co-Lead
Mental Health Goals Programme
Next workstream
Innovative Clinical Trials Hub
